Integrated Micro Nano Opto Fluidic systems for high content diagnosis and stud...
Integrated Micro Nano Opto Fluidic systems for high content diagnosis and studies of rare cancer cells
The project aims at developing a new integrated and automated microfluidic tool for cancer cells screening. This instrument will have a reliability and power much beyond state of the art (capture yield increased by a factor from 1...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BIOMEDMICROFLUIDICS
Modelling and Optimization of Microfluidic Devices for Biome...
100K€
Cerrado
PID2021-126523OB-I00
DESARROLLO DE UN MODELO TRIDIMENSIONAL DE MELANOMA DINAMICO,...
115K€
Cerrado
LOCNANOMOT
New lab on a chip microsystems based on active transport by...
255K€
Cerrado
PID2020-120313GB-I00
MICRO Y NANOTECNOLOGIA, ESTRATEGIAS DE INTEGRACION PARA EL D...
92K€
Cerrado
EQC2018-004433-P
Citómetro de flujo analizador multiparamétrico de alta resol...
110K€
Cerrado
EIN2020-112295
DESCUBRIMIENTO DE NUEVOS MARCADORES DE CANCER EN EL PROTEOMA...
15K€
Cerrado
Información proyecto CAMINEMS
Líder del proyecto
INSTITUT CURIE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
5M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The project aims at developing a new integrated and automated microfluidic tool for cancer cells screening. This instrument will have a reliability and power much beyond state of the art (capture yield increased by a factor from 10X to 100X and multimodal typing of the cells in 3D high resolution images), allowing earlier and more accurate diagnosis, prognosis and selection of treatments of cancers. CaMiNEMS’s new approach will involve a new generation of bio-functionalised multifunctional magnetic nano and microparticles which will be self-assembled by a Hierarchial Templated Self-Assembly mechanism into high-aspect ratio reversible arrays. For highly automated molecular typing of cancers, this key innovation will be integrated with a unique fully automated flow control system working from nanolitres to millilitres and with innovative nano-optics tools and image analysis software. Technological developments will be validated regarding the analysis of circulating tumour cells or micrometastases and the molecular typing of minimally invasive microsamples from tumours. The project will also yield new tools for research and drug-discovery, allowing for the first time to study at the single molecule scale in single cancer cells from patients the fate and action of new generation anticancer drugs using innovative dynamic tracking of Quantum dots. To combine research excellence and societal impact, the consortium involves research groups with complementary competences in microfluidics, nano-optics, biophysics, nanoparticles, biochemistry, informatics, several forefront cancer centres for clinical validation and a research-intensive SME for exploitation.